| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUCUGUCCCCGCGUCGCUCGCUGGCUAGCUCGCUGGCUCGCUCGCCCGU… | 2199 nt | 0.6085 | |
| CUCUGUCCCCGCGUCGCUCGCUGGCUAGCUCGCUGGCUCGCUCGCCCGU… | 2262 nt | 0.6180 | |
| CUCUGUCCCCGCGUCGCUCGCUGGCUAGCUCGCUGGCUCGCUCGCCCGU… | 2154 nt | 0.6123 | |
| CUCUGUCCCCGCGUCGCUCGCUGGCUAGCUCGCUGGCUCGCUCGCCCGU… | 2133 nt | 0.6184 | |
| CUCUGUCCCCGCGUCGCUCGCUGGCUAGCUCGCUGGCUCGCUCGCCCGU… | 2025 nt | 0.6123 | |
| CUCUGUCCCCGCGUCGCUCGCUGGCUAGCUCGCUGGCUCGCUCGCCCGU… | 1935 nt | 0.6072 |
This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
A study in human pediatric sepsis patients identified the BIN1 as exhibiting increased polyadenylation in viral compared to bacterial infection samples through Nanopore direct RNA sequencing [He et al. DOI:10.1186/s12879-025-11078-z].